Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « comparison »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
comparing < comparison < comparisons  Facettes :

List of bibliographic references indexed by comparison

Number of relevant bibliographic references: 89.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000417 (2020) Matthijs S. Van Der Leeuw [Pays-Bas] ; Paco M. J. Welsing [Pays-Bas] ; Maria J. H. De Hair [Pays-Bas] ; Johannes W. G. Jacobs [Pays-Bas] ; Anne C. A. Marijnissen [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Faouzia Fodili [Pays-Bas] ; Reinhard Bos [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas]Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial
000482 (2020) Hitoshi Irabu [Japon] ; Masaki Shimizu [Japon] ; Shuya Kaneko [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
000483 (2020) Antonio Vitale [Italie] ; Giulio Cavalli [Italie] ; Piero Ruscitti [Italie] ; Jurgen Sota [Italie] ; Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Guido Valesini [Italie] ; Lorenza Maria Argolini [Italie] ; Elena Baldissera [Italie] ; Elena Bartoloni [Italie] ; Daniele Cammelli [Italie] ; Giovanni Canestrari [Italie] ; Elena Cavallaro [Italie] ; Maria Grazia Massaro [Italie] ; Paola Cipriani [Italie] ; Ginevra De Marchi [Italie] ; Salvatore De Vita [Italie] ; Giacomo Emmi [Italie] ; Micol Frassi [Italie] ; Roberto Gerli [Italie] ; Elisa Gremese [Italie] ; Florenzo Iannone [Italie] ; Marco Fornaro [Italie] ; Anna Paladini [Italie] ; Giuseppe Lopalco [Italie] ; Raffaele Manna [Italie] ; Alessandro Mathieu [Italie] ; Carlomaurizio Montecucco [Italie] ; Marta Mosca [Italie] ; Ilaria Piazza [Italie] ; Matteo Piga [Italie] ; Irene Pontikaki [Italie] ; Micol Romano [Italie] ; Silvia Rossi [Italie] ; Maurizio Rossini [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Rosaria Talarico [Italie] ; Bruno Frediani [Italie] ; Angela Tincani [Italie] ; Ombretta Viapiana [Italie] ; Gianfranco Vitiello [Italie] ; Paola Galozzi [Italie] ; Paolo Sfriso [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Donato Rigante [Italie] ; Lorenzo Dagna [Italie] ; Roberto Giacomelli [Italie] ; Luca Cantarini [Italie]Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes
000588 (2020) Gerd R. Burmester [Allemagne] ; Jeffrey R. Curtis [États-Unis] ; Huifeng Yun [États-Unis] ; Oliver Fitzgerald [Irlande (pays)] ; Kevin L. Winthrop [États-Unis] ; Valderilio F. Azevedo ; William F. C. Rigby [États-Unis] ; Keith S. Kanik [États-Unis] ; Cunshan Wang [États-Unis] ; Pinaki Biswas [États-Unis] ; Thomas Jones [États-Unis] ; Niki Palmetto [États-Unis] ; Thijs Hendrikx [États-Unis] ; Sujatha Menon [États-Unis] ; Ricardo Rojo [États-Unis]An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data
000634 (2019) Ariane Klein [Allemagne][Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs].
000723 (2019) Fenglong Xie [Royaume-Uni] ; Huifeng Yun [Royaume-Uni] ; Emily B. Levitan [Royaume-Uni] ; Paul Muntner [Royaume-Uni] ; Jeffrey R. Curtis [Royaume-Uni]Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients.
000961 (2019) Mohamed-Eslam F. Mohamed ; Denise Beck ; Heidi S. Camp ; Ahmed A. OthmanPreferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure‐Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib
000A10 (2019) Zhitao Ying [République populaire de Chine] ; Ting He [République populaire de Chine] ; Xiaopei Wang [République populaire de Chine] ; Wen Zheng [République populaire de Chine] ; Ningjing Lin [République populaire de Chine] ; Meifeng Tu [République populaire de Chine] ; Yan Xie [République populaire de Chine] ; Lingyan Ping [République populaire de Chine] ; Chen Zhang [République populaire de Chine] ; Weiping Liu [République populaire de Chine] ; Lijuan Deng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Yanping Ding [République populaire de Chine] ; Xin-An Lu [République populaire de Chine] ; Yuqin Song [République populaire de Chine] ; Jun Zhu [République populaire de Chine]Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma
000A68 (2019) Misaki Suzuki ; Satoshi Shoji ; So Miyoshi ; Sriram KrishnaswamiModel‐Based Comparison of Dose‐Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients
000B65 (2019) Maxime Ma Verhoeven [Pays-Bas] ; Marjolein Jh De Hair [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Johannes Wj Bijlsma [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Attila Pethoe-Schramm [Suisse] ; Michelle Ea Borm [Pays-Bas] ; Evert-Jan Ter Borg [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Floris Pjg Lafeber [Pays-Bas] ; Johannes Wg Jacobs [Pays-Bas] ; Paco Mj Welsing [Pays-Bas]Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
000B77 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
000E36 (2019) Stephanie Finzel [Allemagne] ; Sebastian Kraus [Allemagne] ; Camille Pinto Figueiredo [Allemagne] ; Adrian Regensburger [Allemagne] ; Roland Kocijan [Allemagne] ; Juergen Rech [Allemagne] ; Georg Schett [Allemagne]Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
000E37 (2019) Yoshiki Nagai [Japon] ; Naoto Yokogawa [Japon] ; Kota Shimada [Japon] ; Shoji Sugii [Japon]Comparison of the clinical characteristics and severity of community-acquired pneumonia between patients with rheumatoid arthritis treated with tocilizumab and those treated with TNF inhibitor.
000E38 (2019) Iain B. Mcinnes ; Nicole L. Byers [États-Unis] ; Richard E. Higgs [États-Unis] ; Jonathan Lee [États-Unis] ; William L. Macias [États-Unis] ; Songqing Na [États-Unis] ; Robert A. Ortmann [États-Unis] ; Guilherme Rocha [États-Unis] ; Terence P. Rooney [États-Unis] ; Thomas Wehrman [États-Unis] ; Xin Zhang [États-Unis] ; Steven H. Zuckerman [États-Unis] ; Peter C. Taylor [Royaume-Uni]Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
000E39 (2019) C. Diener [Allemagne] ; G. Horneff [Allemagne]Comparison of adverse events of biologicals for treatment of juvenile idiopathic arthritis: a systematic review.
000E40 (2019) Maureen Mcmahon [États-Unis] ; Brian Skaggs [États-Unis] ; Jennifer Grossman [États-Unis] ; Weng Kee Wong [États-Unis] ; Lori Sahakian [États-Unis] ; Weiling Chen [États-Unis] ; Bevra Hahn [États-Unis]Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE
000E41 (2019) Der-Yuan Chen [Taïwan] ; Fun Yu [Taïwan] ; Li-Wen Tuan [Taïwan] ; Chao-Hsiun Tang [Taïwan]Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan
000E63 (2019) Małgorzata Wojty [Pologne] ; Agnieszka Piekarska [Pologne] ; Michał Kunc [Pologne] ; Konrad Ptaszy Ski [Pologne] ; Wojciech Biernat [Pologne] ; Jan Maciej Zaucha [Pologne] ; Piotr Waloszczyk [Pologne] ; Piotr Lisowski [Pologne] ; Bartosz Kubisa [Pologne] ; Tomasz Grodzki [Pologne]Clinicopathological comparison and therapeutic approach to Castleman disease—a case-based review
000F33 (2019) Ariane Klein ; Ingrid Becker ; Kirsten Minden ; Anton Hospach ; Tobias Schwarz ; Ivan Foeldvari ; Boris Huegle ; Michael Borte ; Frank Weller-Heinemann ; Frank Dressler ; Jasmin Kuemmerle-Deschner ; Prasad Thomas Oommen ; Dirk Foell ; Ralf Trauzeddel ; Christoph Rietschel ; Gerd HorneffBiologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long‐Term Safety Data from the German BIKER Registry
001107 (2018) Sachiyo Oishi [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Chantal Job-Deslandre [France] ; Loic Guillevin [France] ; Jacques Benichou [France] ; René Marc Flipo [France] ; Carole Duquenne [France] ; Francis Guillemin [France] ; Alain Saraux [France]Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort)
001221 (2018) Gablu Kilcher [Suisse] ; Noemi Hummel [Suisse] ; Eva M. Didden [Suisse] ; Matthias Egger [Suisse] ; Stephan Reichenbach [Suisse]Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "comparison" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "comparison" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    comparison
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021